Lifetime utilization of mammography among Maltese women: a cross-sectional survey by Marmara, Danika et al.
RESEARCH ARTICLE Open Access
Lifetime utilization of mammography
among Maltese women: a cross-sectional
survey
Danika Marmarà1,2* , Vincent Marmarà3 and Gill Hubbard1
Abstract
Background: The knowledge of Maltese women not attending the Maltese Breast Screening Programme (MBSP)
for mammography screening is scarce. Previous research has identified two distinct groups of non-attendees: those
who do not attend because a mammogram was taken elsewhere and those who never attended for mammography
anywhere. It is however unknown which determinants are predictive of lifetime attendance ‘anywhere’ and ‘real’ non-
attendance. The present study examines the relationship between ever-using (Lifetime attendees) or never using
mammography (Lifetime non-attendees) and psychosocial - as well as sociodemographic factors, with the aim to
identify predictors that can inform practice.
Methods: Women’s characteristics, knowledge, health beliefs and illness perceptions were compared, based on prior
data of 404 women, aged 50–60 years at the time of their first MBSP invitation. The main variable of interest described
women’s attendance to mammography (LIFETIME ATTENDEES) and no mammography (LIFETIME NON-ATTENDEES).
Data were analyzed using descriptive statistics, chi-square tests, Mann Whitney test, Independent Samples t-test, Shapiro
Wilk test and logistic regression.
Results: During their lifetime, 86.1% of Maltese women (n = 348) were attendees, while 13.9% (n = 56) were
non-attendees. Non-attendees were more likely to be women with a lower family income (χ2 = 13.1, p = 0.
011), widowers (χ2 = 9.0, p = 0.030), non-drivers (χ2 = 7.7, p = 0.006), without a breast condition (χ2 = 14.2, p < 0.001),
who had no relatives or close friends with cancer (χ2 = 8.3, p = 0.016), and who were less encouraged by a physician
(χ2 = 4.9, p = 0.027), unsure of the screening frequency (χ2 = 28.5, p < 0.001), more anxious (p = 0.040) and fearful (p =
0.039). Perceived benefits, barriers, cues to action, self-efficacy and emotional representations were the most significant
variables to describe the differences between lifetime attendees and non-attendees. Perceived barriers and cues to action
were the strongest predictors for lifetime non-attendance (p < 0.05 respectively).
Conclusions: The health beliefs of women who have never attended for mammography during their lifetime should be
targeted, particularly perceived barriers and cues to action. Further research should focus on understanding knowledge
gaps, attitudinal barriers and emotional factors among ‘real’ non-attendees who require a more targeted approach.
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Background
Breast cancer (BC) is the most common type of cancer
in women worldwide [1]. In Malta, it has topped the list
of female cancers and has accounted for an average
incidence of over 280 women over the last 12 years [2].
Early detection of BC renders the possibility of efficient
treatment [3] which would more likely include breast
conservation without chemotherapy [4]. Regular use of
mammography screening at short enough intervals is a
cost-effective way [5] to detect tumours early enough in
order to improve prognosis, reducing mortality and
thereby impacting on survival [4, 6, 7].
Across the globe, lifetime utilization and regular re-
utilization of mammography has been increasing
steadily across the years [3, 7–9]. Despite the known
benefits of breast screening (BS) by mammography
[10–12], also referred to as mammography screening
(MS), various countries have still not reached the
recommended acceptable (> 70%) or desirable (> 75%)
EU benchmarks, according to the European Guide-
lines [13]. Lower utilization rates may be associated
with three main factors: (a) logistical determinants
such as the availability and accessibility of a screening
center, test affordability, time from work or travelling
time [3, 14, 15], (b) psychosocial factors such as
values, expectations and beliefs which affect the way
women transform knowledge regarding mammography
into actual behaviour [16], and (c) socio-demographic
determinants which impact on the way structural and
psychosocial factors predict mammography use [17,
18]. However, most of the literature does not take
into account the context of mammography provision,
such as countries with dual health systems (organized
and private screening).
Although general barriers to screening by mammog-
raphy in Malta have been identified in our earlier study
[19], our findings showed that our screening cohort
consisted of attendees and non-attendees to the Maltese
Breast Screening programme (MBSP); however, we
recognised that the MBSP non-attendees consisted of a
heterogeneous group of women with diverse reasons for
non-attendance. Hence, screening non-attendees were
not a single group of non-compliant Maltese women,
but consisted clearly of two distinct subgroups:
(i) Women, who had obtained a mammogram outside
the MBSP, possibly as a self-initiated action or
routine check-up [15] or as part of private breast
awareness campaigns, which may have been based
on their recognition of susceptibility to BC and
high self-efficacy in preventing BC [20], and
(ii)‘Real’ non-attendees i.e. women who have never
attended anywhere for mammography during their
lifetime.
Considering the fact that the Maltese National Health
System (NHS) comprises both the public and private sec-
tors, and that a national breast screening programme was
introduced at the end of 2009 for women aged 50–60 years
at the time [13], some women chose to go privately for a
mammogram before the year 2009 and still do so to date
rather than taking up the invitation to be screened at the
MBSP. However, it is the diversity of ‘real’ non-attendees
[15] that needs to be better understood in order to develop
culturally sensitive interventions.
Nothing is yet known to date about those who never
attend for mammography throughout their lifetime in
Malta. Hence, this study was carried out to provide an
understanding of the determinants of lifetime mammog-
raphy screening behaviour among Maltese women who
attend ‘anywhere’ and those who have ‘never’ attended
for mammography. This paper is “part two” of a larger
study that was conducted on breast screening uptake in
Malta carried out through a national cross-sectional
survey and hence, this paper is a continuation of that
previous article. In this paper, data from that 2015
Maltese national survey were used to assess the relation-
ships of lifetime mammography utilization (attendance
‘anywhere’) and ‘real’ non-attendance with socio-
demographics, health status, knowledge, health beliefs
and illness perception variables, based on the Health
Belief Model (HBM) and Common-Sense Model (CSM).
Both HBM and CSM have been used as theoretical
frameworks to predict the uptake of mammography
screening [21–24]. The CSM has been used to consider
the cognitive and emotional representations of an illness
[23] which are often omitted in the use of HBM. On the
other hand, the CSM does not describe the perceived
barriers and benefits to the performance of health-
related behaviours [21] such as mammography use, and
excludes the role of significant others such as family,
friends and healthcare providers [25]. By contrast, the
HBM addresses all of these, incorporating the compo-
nents of perceived benefits, perceived barriers and cues
to action. Following the simultaneous use of both
models which were found to improve the prediction of
non-attendance to the MBSP in our earlier study [19],
both models were again utilised to integrate the beliefs
about the illness (CSM) [26] and the individual’s beliefs
on the recommended behaviour [HBM] [21] in this
study on lifetime mammography utilization.
Guided by the guidelines ‘Strengthening the Reporting
of Observational Studies in Epidemiology’ (STROBE)
[27] [see Additional file 1], we built on the findings of
our prior study [28] which suggest that health beliefs
and illness perceptions vary between women who accept
or refuse a BS invitation to the organized programme.
The immediate aim of our study was to gain an under-
standing of the determinants of lifetime mammography
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use among women who attend for mammography
‘anywhere’ and those who never attend for mammog-
raphy during their lifetime (‘real’ non-attendance).
Objectives
In reaching our aims, this analysis has targeted the
following objectives:
(1)To determine the socio-demographics, health status,
knowledge, health beliefs and illness perceptions of
women who attend or do not attend for
mammography screening during their lifetime;
(2)To examine the most significant predictors of
lifetime mammography utilization and its non-use.
Methods
Design and setting
Since this study was part of a 2015 national retrospective
study, the full details of the methods are described
elsewhere [19]. The MBSP was set up to serve as the
only centre in Malta to offer national screening as part
of an organized programme. As is the current practice at
the MBSP, two views (medio-lateral and cranio-caudal)
are carried out by trained radiographers (mammogra-
phers) and the mammograms are reported by trained
breast radiologists. Adjunct ultrasound is carried out at
a subsequent (recall) appointment when deemed necessary,
for cases such as dense breasts or for further evaluation of
suspected mammographic abnormalities.
A stratified random sample was ascertained from
women aged 50–60 at the time of their first invitation at
the MBSP who were registered on the MBSP database
and who had no personal history of BC. The original
study recruited a sample size of 404 women (i.e. 243
attendees and 161 non-attendees) in order to achieve a
95% confidence level and 5% confidence interval, which
the present study used.
For those invited to the MBSP, attendance or non-
attendance was verified through screening records but
further mammography performed in private practices
was self-reported. Participants were assured that their
participation was voluntary and that they could
withdraw from the study at any time without the need
to give a reason. Information was provided to the
women on how the researcher would protect their
anonymity and confidentiality through coding. Prior to
the commencement of the survey, participants were
informed that the study was aimed at improving the
understanding of women’s beliefs, attitudes and percep-
tions on and concerns about BS and BC. Moreover, they
were notified that the study had been granted ethical
approval by the School Research Ethics Committee at
the University of Stirling (SREC14/15-Paper No.18v4)
and by the Maltese Health Ethics Committee (HEC 02/
2015). As approved by the ethics committees and
following standard practice when conducting surveys
by telephone [29–31], a research assistant was respon-
sible for participant recruitment, which was carried out
manually over the phone (through “yes” or “no”
response options), using paper format to record verbal
informed consent. Following the latter method, an
appointment was scheduled by the research assistant to
match its suitability for each of the participants and the
primary investigator (DM). The survey was completed
in a median of 25 min (range, 15–45 min) and was
carried out in one telephone call.
Survey development
The survey questionnaire consisted of standardized
socio-demographic and health status questions as well as
validated scales (CHBMS-MS and IPQ-R) [32, 33]. All
measures were translated from English to Maltese using
a back-translation procedure. A pre-test (n = 15) of the
121-item tool (entitled the Maltese Breast Screening
Questionnaire – MBSQ) confirmed the comprehensibil-
ity, accuracy and feasibility of the questionnaire and to
ensure understanding of scale items in both Maltese and
English. The methods used have been published else-
where [19, 34].
The survey questionnaire is composed of four sections,
as follows:
1) Socio-demographic factors and health status were
measured through 11 subscales (20 items),
2) Lifetime mammography practices and knowledge of
mammography frequency were measured through 4
subscales (17 items),
3) Health beliefs were measured through 5 subscales
(36 items),
4) Illness perceptions were measured through 7
subscales (48 items).
Response options were “yes”, “no” or a series of tick
boxes for socio-demographic factors and health status
variables. Open questions were designed to encourage a
more detailed and meaningful answer using the partici-
pant’s own knowledge and/or feelings. Most of the
response options for lifetime mammography practices
and knowledge on mammography time intervals were
mostly designed to elicit “yes”, “no” or “unsure” answers,
whereas closed questions were possible through a series
of tick boxes. All items for health beliefs and illness per-
ceptions had 5 response options (1 = ‘strongly disagree’
to 5 = ‘strongly agree’).
Classification of variables
Women were asked if they ever had a mammogram in their
lifetime with a yes/no response. Women were categorized as
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LIFETIME ATTENDEES if they had ever had a mammo-
gram in their lifetime or LIFETIME NON-ATTENDEES if
they had never attended for a mammogram during their life-
time. Socio-demographic and health status variables (some
of which were confirmed from women’s health records from
the screening database), as well as knowledge of screening
frequency, health beliefs and illness perception variables
were collected from the survey administered retrospectively
from the time of the first screening invitation at the MBSP.
Statistical analysis
The chi-square test was used for comparison of propor-
tions between two categorical variables. The Shapiro Wilk
test was applied on the 14 constructs in order to deter-
mine whether these variables are normally distributed. It
was found that only the variable Causes of BC was nor-
mally distributed. Hence, parametric tests were used for
this latter construct. All the other 13 constructs were
found to be not normally distributed (p-value < 0.001) and
hence, non-parametric tests were used for all the 13
constructs. When comparing two independent samples,
the Independent Samples t-test was used for normally dis-
tributed data (parametric test) and Mann-Whitney test
was used for the non-normal distributed dataset (non-
parametric test). Similarly, for analysis including two of
more independent samples, ANOVA was used for
normally distributed data and Kruskal-Wallis test was
used for the non-normal distributed datasets. Different
variables and constructs were incorporated into six logistic
regression models and the ‘backward-elimination’ method
was applied to each model to identify the significant
predictors of lifetime mammography use. The results of
the regression are reported with 95% confidence intervals,
Beta (unstandardized) coefficients, Standard Errors (SE),
Walds, Odds Ratios (OR) and p-values. All tests were
analysed with an α = 0.05 level of significance; hence, any
statistical test obtaining a p-value of < 0.05 was considered
as statistically significant. Missing data was minimal (n =
23 for frequency of GP visit) and this missing data was
reported in our previous paper [19]. Missing data was
reported as is; hence this data was not excluded. The data
was analyzed using SPSS version 21.
Results
Sample characteristics
Most participants (86.9%) were married (n = 351).
The majority (77%) of participants were housewives
(n = 311), 75.7% had a secondary level of education
(n = 306) and more than half (60.3%, n = 244) were
from below average annual income families (lower
than €16,113). Descriptive statistics are presented in
our previous paper [19].
Mammography screening practices
Mammography screening practices are presented in
Fig. 1. Breast screening use (LIFETIME ATTENDEES)
was reported by 86.1% of women (n = 348), of which
243 women underwent a mammogram at the MBSP.
From those who did not undergo a mammogram at the
MBSP (n = 161), 105 women underwent mammography
elsewhere. No mammography was reported by 13.9%
(n = 56) (LIFETIME NON-ATTENDEES).
LIFETIME ATTENDEES versus LIFETIME NON-ATTENDEES
subgroup analyses
Chi-square tests were performed to explore associations
between lifetime attendees and non-attendees, and the
following variables: sociodemographic factors, health
status, knowledge, health beliefs and illness perceptions.
Sociodemographic factors and health status
There was significant association between marital status
and lifetime mammography (χ2 = 9.0, p = 0.030) such
that a lower number of widowers attended for mammog-
raphy (66.7%) when compared to women of other
statuses (single, married, separated/divorced) (≥87%).
The higher their family income, the more likely it is for
a woman to undergo mammography in her lifetime (χ2
= 13.1, p = 0.011). In fact, all women who had a family
annual income greater than €23,564 claimed that they
acquired mammography during their lifetime while from
those with a family annual income lower than €10,737,
around one in every four women did not undergo mam-
mography. In addition, those who do not drive are more
likely not to attend for a mammogram (χ2 = 7.7, p =
0.006). Our data showed that 91.5% of drivers attended
for a mammogram in their lifetime as compared to
81.9% of non-drivers. All women in our sample with a
breast condition or disease attended for mammography
in their lifetime when compared to 82.9% of women
without a breast condition (χ2 = 14.2, p < 0.001). More-
over, those who had relatives or close friends with cancer
were more likely to attend for mammography (χ2 = 8.3,
p = 0.016).
No significant association was found between lifetime
mammography and age (Independent samples t-test:
p = 0.133), district (χ2 = 7.8, p = 0.802), owning a car (χ2
= 1.2, p = 0.267) or having an illness (χ2 = 0.1, p = 0.709).
Although there was no significant association for level of
education (χ2 = 5.4, p = 0.067) and occupation (χ2 = 5.7,
p = 0.057), women with a higher education level and
who were employed were more likely to undergo
mammography in their lifetime (e.g. 93.2% {employed}
versus 83.9% {housewives}). There was no significant
association between having a family physician and life-
time mammography (χ2 = 3.5, p = 0.060). However,
women who were not encouraged by their GP were
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more likely not to attend for a mammogram during their
lifetime (χ2 = 4.9, p = 0.027).
Knowledge of the recommended mammography frequency
Knowledge of mammography frequency was significantly
associated with whether women had undergone a
mammogram in their lifetime (χ2 = 28.5, p < 0.001). The
main difference arises with those who said they were
‘unsure’ about the recommended mammography
frequency (48% of the latter group did not undergo a
mammogram in their lifetime), whereas for women who
mentioned other mammography frequency options (i.e.
‘every year’; ‘every 1.5 years’; ‘every 2–3 years’), more
than 86% of women from each individual latter groups
had acquired a mammogram.
Health beliefs
All sub-scale items for perceived barriers and cues to
action for mammography use were found to be statisti-
cally significant (p < 0.05) (Table 1). Women tend to
attend less for mammography if they are in agreement
with or are undecided on the following: having a
mammogram ‘would make you more anxious’, ‘more
worried’, ‘more fearful about BC’ and ‘the procedure itself ’,
is ‘embarrassing’ and ‘time-consuming’ and ‘causes
unnecessary radiation’, have ‘fear or distrust the medical
team’, ‘consider other problems in life to be greater’ and
feel they are ‘not old enough to have a mammogram
periodically’ (p < 0.001 respectively). Significant associ-
ation is mirrored for the statement ‘you fear having a
mammogram because you know someone (family or
friend) with breast cancer’ (p < 0.001). When comparing
pain and discomfort with mammography use, statistical
significance is mirrored (p < 0.001), whereby the abso-
lute majority of the undecided group (95.8%) do not
attend for a mammogram in their lifetime whereas those
who are in disagreement or in agreement (≥88%) attend
for mammography.
Those who underwent mammography tend to attend
more for mammography if advised by their GP (χ2 =
54.4, p < 0.001) or by relatives or friends (χ2 = 16.9, p =
0.001). Those who are in disagreement that hearing
about BC and BS in the media would trigger thoughts to
get a mammogram tend to attend less. The absolute
majority of those who are in disagreement that cues to
action (such as ‘reminder letters’, ‘reminder phone calls’
or ‘text messages’) are effective, are more likely not to
attend for mammography. There is also similar
significant association for the vast majority of self-
efficacy sub-scale items (p < 0.001) i.e. for attendees, the
stronger is women’s confidence in arranging other things
in their life to get a mammogram, while for the
undecided group and those who are in disagreement
with self-efficacy items are more likely not to attend for
mammography screening.
Illness perceptions
There is significant association for the emotional repre-
sentation subscale items (p < 0.05) (Table 2). For
lifetime non-attendees, the higher is their anxiety (χ2 =
8.3, p = 0.040) and fear (χ2 = 8.3, p = 0.039) of BC. The
undecided group attend less for mammography when
Fig. 1 Mammography use in Malta
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taking into account that their emotional state (χ2 = 12.9,
p = 0.002) and their own behaviour (χ2 = 12.7, p = 0.002)
is perceived to possibly cause BC. Those who agree that
BC can be caused by their own behaviour (χ2 = 12.7,
p = 0.002) or by a germ/virus (χ2 = 9.4, p = 0.009) attend
less for mammography, while those who consider BC to
have major consequences in life (χ2 = 9.9, p = 0.019)
attend more.
Health beliefs and illness perception constructs
The following 4 HBM and 1 CSM constructs were found
to be significantly different when comparing lifetime
mammography attenders and non-attenders: perceived
benefits, perceived barriers, cues to action, self-efficacy
(p < 0.001 respectively) and emotional representations
(p = 0.033) (Table 3).
Table 1 Health Belief items
LIFETIME SCREENERS
versus
NON-SCREENERS
Health Beliefs χ2 p-value
There is no possibility of getting
breast cancer (r)
8.4 0.077
Your chances of getting breast
cancer are high
8.2 0.085
There may be the possibility of
developing breast cancer in your lifetime
3.0 0.390
When you get a mammogram, you
feel good about yourself
45.5 < 0.001*
When you get a mammogram, you
do not worry as much about breast cancer
6.4 0.093
Having a mammogram will help you find
lumps early in your breasts
19.1 < 0.001*
If you find a lump through a mammogram,
the treatment for breast cancer may not be
as bad
5.2 0.160
Having a mammogram will decrease your
chances of dying from breast cancer
7.5 0.580
Having a mammogram will help you find
a lump before it can be felt by yourself or
a health professional
7.2 0.065
Having a routine mammogram would
make you anxious about breast cancer
27.7 < 0.001*
Having a routine mammogram would
make you worry
22.8 < 0.001*
You fear having a mammogram because
you might find out that something is wrong
39.7 < 0.001*
You fear having a mammogram because
you do not know the procedure or what
to expect
145.8 < 0.001*
You fear having a mammogram because
you know someone (family or friend) with
breast cancer
20.0 < 0.001*
It is embarrassing for you to have a
mammogram
40.4 < 0.001*
Undergoing mammography will be
painful or uncomfortable
147.5 < 0.001*
Having a mammogram is time consuming 31.1 < 0.001*
You are discontent with Breast Screening
personnel as they have been rude to you
n/a n/a
You have fear or distrust in the medical team 32.9 < 0.001*
Having a mammogram would expose you
to unnecessary radiation
27.9 < 0.001*
You have too many other problems in your
life than to get a mammogram done
83.1 < 0.001*
You are not old enough to have a
mammogram periodically
35.4 < 0.001*
If your GP advises you to attend for a
mammogram, you will attend
54.4 < 0.001*
If your relatives or friends advise you to
attend for a mammogram, you will attend
16.9 0.001*
Table 1 Health Belief items (Continued)
LIFETIME SCREENERS
versus
NON-SCREENERS
Health Beliefs χ2 p-value
If someone close to you has been
diagnosed with breast cancer, you will
attend for a mammogram
39.4 < 0.001*
Hearing about breast cancer and breast
screening in the media or news makes
you think about getting a mammogram
34.2 < 0.001*
Reminder letters would help you to get
a mammogram
38.9 < 0.001*
Reminder phone calls or text messages
would help you to get a mammogram
38.9 < 0.001*
Routine educational talks regarding
breast cancer awareness would help
you to get a mammogram
37.1 < 0.001*
You feel confident that if you had a
mammogram done, any abnormalities
in your breasts will be detected
0.6 0.960
You can arrange other things in your life
to get a mammogram
49.2 < 0.001*
In case you need a mammogram, you will
find a place to get it done
32.8 < 0.001*
You can make an appointment for
a mammogram
36.0 < 0.001*
You can arrange transportation to get
a mammogram
41.1 < 0.001*
You can talk to people at the breast
screening centre about your concerns
n/a n/a
You can find a way to pay for a mammogram
if you need to
32.3 < 0.001*
*Statistically significant
(r) = reverse scored
aChi-square test was applied for all health beliefs; hence the categorical
answers were used to apply this test for association. For each question,
respondents were asked to select a number between 1 and 5, where 1 =
strongly disagree and 5 = strongly agree. For certain items, responses were re-
grouped to ensure the feasibility of the Chi-square test
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The findings show that for women who acquire
mammography during their lifetime, the higher is their
agreement on perceived benefits to mammography
uptake, while more cues to action and greater self-
efficacy help women to undergo mammography. Higher
perceived barriers to mammography screening and
stronger emotional representations of BC are associated
with no mammography use during a woman’s lifetime.
Predictors of mammography screening practices
We further explored which variables and constructs
were most significant to women’s attendance (LIFETIME
ATTENDEES versus LIFETIME NON-ATTENDEES). A
number of logistic regression models were applied
(Table 4) in order to examine the variables/constructs
(independent variables) which are key to identifying
Table 2 Illness Perception items
LIFETIME
SCREENERS
versus
NON-SCREENERS
Illness Perceptions χ2 p-value
The presence of a lump or thickening
in the breast
1.8 0.611
Nipple discharge 2.3 0.509
Sudden nipple retraction 1.1 0.769
Change in shape or appearance of
the nipple
1.2 0.743
Breast swelling, dimpling, redness or
soreness of the skin
0.9 0.826
Skin changes of the breast 1.7 0.641
A sudden change in breast size 1.5 0.688
Aching breasts 1.5 0.820
Stress or worry 3.0 0.223
Your mental attitude (e.g. thinking
about life negatively)
2.0 0.580
Family problems or worries 2.9 0.233
Overwork 7.9 0.052
Your emotional state (e.g. feeling down,
lonely, anxious, empty)
12.9 0.002*
Your personality 3.0 0.391
Hereditary - it runs in the family 9.7 0.021*
Diet or eating habits 1.5 0.679
Poor medical care in the past 0.8 0.847
Your own behaviour 12.7 0.002*
Ageing 1.9 0.395
Smoking 1.8 0.601
Alcohol 1.2 0.538
A germ or virus 9.4 0.009*
Pollution in the environment 1.4 0.709
Altered immunity 2.5 0.469
Chance or bad luck 3.0 0.562
Accident or injury 3.6 0.460
Breast cancer will last a short time 5.8 0.120
Breast cancer is likely to be permanent
rather than temporary
0.9 0.650
A patient with breast cancer goes
through cycles in which her illness
gets better and worse
5.8 0.215
Breast cancer has major consequences
on a patient’s life
9.9 0.019*
Breast cancer will not have much effect
on your life
6.1 0.189
Breast cancer would strongly affect the
way others see you
7.8 0.100
Breast cancer has serious economic
and financial consequences
5.0 0.174
Table 2 Illness Perception items (Continued)
LIFETIME
SCREENERS
versus
NON-SCREENERS
Illness Perceptions χ2 p-value
Breast cancer would strongly affect the way you see
yourself as a person
0.9 0.826
Breast cancer would threaten a relationship with your
husband or partner
2.5 0.641
If you had breast cancer, your whole life
would change
5.6 0.133
If you developed breast cancer, the chances
of living a long life would decrease
4.9 0.179
There is a lot which you can do to control
the symptoms if Breast Cancer occurs
0.7 0.948
The course of Breast Cancer will depend
on your actions
2.9 0.400
Your actions will have an effect on the
outcome of Breast Cancer
4.0 0.261
There is no treatment that will help to
improve Breast Cancer
4.0 0.400
The treatment provided will be effective
in controlling or curing Breast Cancer
3.1 0.371
The negative effects of Breast Cancer can be
prevented or avoided by the treatment given
1.5 0.822
You have a clear picture and understanding
of Breast Cancer
4.5 0.211
Breast Cancer is a mystery to you 2.1 0.720
You get anxious when you think about
Breast Cancer
8.3 0.040*
Breast Cancer makes you feel afraid 8.3 0.039*
You get worried when you think about
Breast Cancer
4.3 0.231
*Statistically significant
aChi-square test was applied for all health beliefs; hence the categorical
answers were used to apply this test for association. For each question,
respondents were asked to select a number between 1 and 5, where 1 =
strongly disagree and 5 = strongly agree. For certain items, responses were re-
grouped to ensure the feasibility of the Chi-square test
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differences between women who attended mammog-
raphy during lifetime and non-attendees (dependent
variables). Model 1 represents the demographics against
attendance/non-attendance. Although ‘drive’ and ‘status’
variables were found to be significant (p < 0.05), this
model was not found to provide any accuracy to predict
non-attendance. Hence, demographics are not providing
any useful prediction for the scope of this analysis.
Model 2 focused on Health Belief variables only, which
served as the independent variables for this model. This
model predicted attendance with an accuracy of 98.3%
and non-attendance with an accuracy of 48.2%. Five
variables were found to be significant (p < 0.05) with an
Odds Ratio (OR) that varies between 0.213 (fear of
unknown procedure) and 3.327 (arrange transportation)
for all the five variables. Model 3 focused on Illness
Perception variables only, which served as the independ-
ent variables for this model. This model predicted
attendance with an accuracy of 99.4% and non-
attendance with an accuracy of 5.4%. Six variables were
found to be significant (p < 0.05) with OR varying
between 0.432 (fear of breast cancer) and 1.926 (major
consequences in life). The above significant predictors
from both models 2 and 3 were incorporated into a new
single model (Model 4), both health beliefs and illness
perception variables serving as the independent variables
for this model. The model accuracy, when combining
both scores, improved to 98.0% for attendance and
53.6% for non-attendance. The model retained six
significant predictors (p < 0.05) with OR varying
between 0.212 (fear of unknown procedure) and 3.202
(arrange transportation). When all individual Health
Belief and Illness Perception items were incorporated
into one model (Model 5), eight variables were found to
be significantly different (p < 0.05) with OR varying
between 0.149 (fear of unknown procedure) and 3.716
(arrange transportation). The accuracy of the model
improved again to 97.1% for attendees and 58.9% accur-
acy for non-attendees. When the 14 constructs (not
individual items) related to Health Beliefs and Illness
Perceptions were used to construct a logistic regression
model (Model 6), ‘perceived barriers’ (OR 0.776) and
‘cues to action’ (OR 1.196) were found to be the stron-
gest and most significant predictors (p < 0.05) to
describe the variance between the subgroups. However,
the accuracy for predicting the non-attendees was found
to be 37.5% and 96.6% for predicting attendance, which
is inferior when compared to Model 4. No health status
variables were found to be significant and were therefore
not included in Table 4.
Discussion
The extant research identifies multifactorial reasons why
women choose not to attend for mammography screening
[9, 35–39], particularly psychological, socio-economic and
practical factors [15, 28, 40, 41]. Hence, this study was
carried out to provide an understanding of the determi-
nants of lifetime mammography use among Maltese
women who attend ‘anywhere’ and those who ‘never’
attend for mammography. This study found that four
health belief constructs (perceived benefits, perceived
barriers, cues to action, self-efficacy) and one illness
perception construct (emotional representations) influ-
ence lifetime mammography screening practices among
Table 3 Comparisons between mammography screening use and health beliefs/illness perception constructs. For all constructs,
Mann Whitney test and Independent Samples t-test were applied to compare ‘LIFETIME ATTENDEES’ and ‘LIFETIME NON-ATTENDEES’
LIFETIME ATTENDEES
(n = 348)
LIFETIME NON-ATTENDEES
(n = 56)
Test Statistic p-value
Perceived Susceptibility M = 9.6, SD = 1.0 M = 9.6, SD = 1.0 10,065.5a 0.669
Perceived Benefits M = 24.0, SD = 1.8 M = 23.1, SD = 1.5 6816.5a < 0.001*
Perceived Barriers M = 27.5, SD = 4.9 M = 34.8, SD = 4.9 16,569.5a < 0.001*
Cues to action M = 27.3, SD = 3.2 M = 23.1, SD = 4.8 4306.0a < 0.001*
Self-Efficacy M = 24.8, SD = 2.7 M = 22.7, SD = 2.8 6114.5a < 0.001*
Breast Cancer Identity M = 30.6, SD = 2.3 M = 30.7, SD = 2.0 10,344.0a 0.434
Causes of Breast Cancer M = 56.0, SD = 7.2 M = 57.4, SD = 6.9 -1.3b 0.186
Cancer Timeline: Acute/Chronic M = 6.1, SD = 0.9 M = 6.2, SD = 0.9 10,213.5a 0.534
Cancer Timeline: Cyclical M = 3.6, SD = 0.7 M = 3.4, SD = 0.7 8513.0a 0.069
Consequences M = 28.2, SD = 2.5 M = 28.5, SD = 2.0 9909.0a 0.837
Personal Control M = 11.8, SD = 0.8 M = 11.9, SD = 0.5 9890.0a 0.757
Treatment Control M = 9.9, SD = 0.7 M = 10.0, SD = 0.5 10,592.0a 0.119
Illness Coherence M = 7.0, SD = 1.1 M = 7.0, SD = 1.1 9857.5a 0.880
Emotional Representations M = 12.2, SD = 2.1 M = 12.7, SD = 2.5 11,431.5a 0.033*
*Statistically significant, a Mann Whitney test, b Independent Samples t-test
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Table 4 Logistic Regression Models on lifetime mammography use (LIFETIME ATTENDEES versus LIFETIME NON-ATTENDEES) against
different variables and different constructs
B SE Wald P-value OR 95% CI Model Accuracy
Attendance
Model Accuracy Non-
attendance
Model 1: Demographics 100% 0%
Drive 0.912 0.325 7.891 0.005 2.488 1.317, 4.700
Status 0.591 0.224 6.987 0.008 1.807 1.165, 2.801
Constant −4.605 0.792 33.773 0.000 0.010
Model 2: Health Beliefs 98.3% 48.2%
Fear of unknown procedure −1.548 0.219 50.028 0.000 0.213 0.138, 0.327
Other life problems −1.213 0.302 16.130 0.000 0.297 0.165, 0.537
Relative or close friend with breast cancer 0.383 0.187 4.218 0.040 1.467 1.018, 2.114
Reminder letters 1.099 0.307 12.826 0.000 3.001 1.645, 5.475
Arrange Transportation 1.202 0.410 8.605 0.003 3.327 1.490, 7.427
Constant −1.993 2.109 0.893 0.345 0.136
Model 3: Illness Perceptions 99.4% 5.4%
Hereditary 0.579 0.233 6.179 0.013 1.784 1.130, 2.816
Own behaviour −0.554 0.213 6.774 0.009 0.575 0.379, 0.872
Major consequences in life 0.655 0.255 6.627 0.010 1.926 1.169, 3.172
Economic consequences 0.520 0.238 4.777 0.029 1.683 1.055, 2.683
Threatens your relationship −0.396 0.178 4.973 0.026 0.673 0.475, 0.953
Fear of breast cancer −0.840 0.280 9.038 0.003 0.432 0.250, 0.746
Constant 1.060 1.828 0.337 0.562 2.888
Model 4: Health Beliefs and Illness Perceptions 98.0% 53.6%
Fear of unknown procedure −1.553 0.224 48.123 0.000 0.212 0.136, 0.328
Other life problems −1.239 0.310 15.973 0.000 0.290 0.158, 0.532
Relative or close friend with breast cancer 0.407 0.189 4.618 0.032 1.502 1.036, 2.178
Reminder letters 1.123 0.316 12.638 0.000 3.074 1.655, 5.710
Arrange transportation 1.164 0.411 8.028 0.005 3.202 1.432, 7.163
Own behaviour −0.612 0.288 4.536 0.033 0.542 0.309, 0.952
Constant −0.240 2.306 0.011 0.917 0.787
Model 5: Health Beliefs and Illness Perceptions 97.1% 58.9%
Poor medical care 0.878 0.360 5.970 0.015 2.407 1.190, 4.870
Own behaviour −1.195 0.380 9.893 0.002 0.303 0.144, 0.637
Pollution 0.603 0.283 4.543 0.033 1.829 1.050, 3.185
Possibility of developing breast cancer −1.295 0.658 3.876 0.049 0.274 0.075, 0.994
Fear of unknown procedure −1.907 0.268 50.587 0.000 0.149 0.088, 0.251
Other life problems −1.478 0.331 19.976 0.000 0.228 0.119, 0.436
Reminder letters 1.256 0.321 15.352 0.000 3.512 1.874, 6.584
Arrange transportation 1.313 0.442 8.832 0.003 3.716 1.564, 8.831
Constant 3.476 3.406 1.041 0.308 32.328
Model 6: The 14 constructs 96.6% 37.5%
Perceived barriers −0.253 0.039 43.157 0.000 0.776 0.720, 0.837
Cues to action 0.179 0.041 19.169 0.000 1.196 1.104, 1.295
Constant 5.192 1.688 9.460 0.002 179.859
B unstandardized coefficients; SE standard error; OR odds ratio; CI confidence interval
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Maltese women. In particular, our findings show that
women who perceive more barriers to mammography
attendance (e.g. fear of pain, fear of the result), fewer
benefits (e.g. lower belief in early detection), lower cues to
action (e.g. no advice by a GP) and lower self-efficacy (e.g.
lower confidence in one’s ability to arrange other things in
life), and who have higher emotional representations of
BC (e.g. greater fear, worry, anxiety and who consider
other problems in life to be greater) were less likely to
attend for mammography during their lifetime. This is
consistent with Champion’s Health Belief Model and
Leventhal’s Common-Sense Model of self-regulation. This
also implies that women who have previously experienced
mammography screening may already have established
health-related behaviours [42] and have therefore already
recognized the benefits of undergoing regular mammog-
raphy use, have already overcome personal barriers to
undergo mammography, have increased their self-
confidence in getting screened throughout their lifetime
and have higher levels of health motivation [23, 28, 42–
44]. Therefore, efforts should be focused on identifying
and encouraging attendance among women who have
never participated in screening [44].
Our findings emphasize the importance of adapting
interventions for women with lower socio-economic
backgrounds, particularly since widowers, those having
lower family incomes and non-drivers were found to be
significantly associated with lifetime non-attendance in
this study. These women are less likely to attend for
screening anywhere. Women with socio-economic
disadvantages in life are less likely to take part in any
mammography screening. This relationship has been
shown in previous literature [45]. Having a free-of-
charge, invitational, organized screening programme is
one of many interventions which would help to increase
mammography use. This socioeconomic difference is re-
emphasized in our previous study whereby household
income has solely emerged as significantly associated
with attendance to first invitation at the MBSP [19]. Al-
though not statistically significant in this present study,
women with a higher level of education and in employ-
ment were found to be more likely to attend than non-
employed women and those with a lower education
level. These socio-economic characteristics may serve as
a proxy for interaction with other people, and in the
degree of social integration during a woman’s lifetime.
These findings may indirectly reflect social differences as
well as the degree of equality regarding detection of BC
and treatment received, and may help to identify
prognostic factors amenable to intervention.
There were significant associations in this study between
lifetime attendees and non-attendees regarding having a
breast condition or BC in the family and the close rela-
tions, such that women with a breast condition or who
had relatives or close friends with cancer were more likely
to attend for mammography during their lifetime. Simi-
larly, having a family member or close friends with BC
was found to be associated with mammography attend-
ance in other studies [46, 47] but contrast others [48–50].
Women most often play key roles as health managers and
family caregivers [51–53] and this is not only reflected in
that women more regularly than men are searching for
health-related information on the Internet [54] but in
women seeking a preventive action when faced with a
prior personal or close relation experience that subse-
quently triggers them to engage in a health-related behav-
iour [50, 55, 56]. This corresponds with other research in
other fields, particularly on mothers and children [57].
It has been acknowledged that lifetime non-attendees
are an extremely difficult group to target and are a real
challenge for screening management and public health
officials [58]. For instance, structural and socio-economic
factors such as age, income and marital status cannot be
directly or easily modified [59]. Hence, although the
exploration of such variables can help identify those at risk
for a poor screening profile, such research offers little
direction in terms of viable interventions. Therefore, in
order to better understand which constructs are most
significant to lifetime mammography non-attendees in
Malta, our logistic regression analyses confirmed that
health beliefs were the strongest and most important
predictors to lifetime non-attendance and this result has
been consistent across our previous research on first
invitation to the MBSP [19], re-attendance [28] and adher-
ence to timely mammography use [60]. This implies that
lifetime non-attendees are women who were not
motivated in health behaviour, have strong emotional rep-
resentations of BS and BC, who highlight more barriers to
screening, lower benefits and less cues to action because
this is a new skill for them. This is evidenced by women
who do not attend for mammography in other countries
[59, 61] because they perceive greater barriers to BS.
Our data shows evidence that lifetime non-attendees
were less encouraged by their GP to attend for a mam-
mogram during their lifetime. However, it is also true
that Maltese women tend to visit their GPs when they
have a problem rather than on a routine basis [19].
While it is known that GPs are significantly more influ-
ential than relatives or friends at supporting the uptake
of BS by mammography [55], women obtain information
more often from friends and relatives than from official
sources [62]. This reinforces the influence of word of
mouth from friends and relatives as a means of screen-
ing promotion [55], supporting related promotional
schemes worldwide [63–65]. However, while word of
mouth is important, such initiatives are aimed at ensur-
ing that information passed through word of mouth is
based on factual information, rather than emotional
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reasons [55]. Although physician recommendation is
critical for the provision of factual information (about
BS, BC and adherence recommendations) [59, 66], many
women still do not screen frequently enough [59].
Hence, it seems increasingly clear that interventions
should be developed to target variables that are both
amenable to change and for which there is scope for im-
provement, if breast screening rates are to be improved.
Emotional representations play a central role in models
of both self-regulation and health behaviour [66] as well
as in models regarding the “uptake” of health-promoting
messages [67]. However, research cannot determine
exactly what women are afraid of or how the diverse fear
components are related to one another or to screening
behaviour, particularly since contradictory findings across
studies make it difficult to draw conclusions from the
literature. Hence, fear, anxiety and worry are often termed
to encompass nearly “everything” [59]. Our current study
investigated barriers related to fear more specifically and
we found that fear is certainly related to a breast cancer
diagnosis, fear of pain/discomfort, fear of embarrassment,
fear of the medical establishment, radiation, as well as
general worry and anxiety. Similarly, other research found
that fear is instilled due to an awaited result that may
cause a negative impact on the self and on the family [59,
61, 68, 69], due to the pain perceived or experienced
during the test [15, 44, 49, 70, 71], due to the sense of
uncomfortableness whereby one exposes such an intimate
body part in front of another person [44, 45, 71, 72], fear
of the medical team [59, 73], fear that X-rays would cause
more harm than good to the breast [15, 45] and nonspe-
cific “cancer worry” [45, 49, 59, 74, 75] and general anxiety
[76, 77]. Studies suggest that mammography-related
anticipatory anxiety may contribute to poorer adherence
[15, 69, 78] because women may avoid undergoing
mammography to reduce their anxiety. It is possible that
reports of mammography-related anxiety and catastro-
phizing thoughts related to mammography pain reflect
women’s level of general anxiety [79, 80]. This may also
operate as a barrier for relatives or friends to undergo
mammography or attend a particular unit [81]. Hence,
such concerns need also to be taken seriously to encour-
age long-term adherence among attendees by finding ways
how to avoid pain and maintaining client satisfaction [82,
83]. Women can be prepared for mammography by
informing them about possible short-lived pain or discom-
fort, preferably in the invitation letter or in screening cam-
paigns [15]. Additionally, calming self-statements or
distraction techniques could be utilised to reduce the fear
of pain and embarrassment during the test [23].
The undecided group of women in this study tend to
attend less for mammography screening, particularly
those who are unsure about: (i) self-efficacy items such
as whether they can arrange other things in life to get a
mammogram, (ii) screening barriers such as whether
mammography is painful or uncomfortable, (iii) illness
perception items such as whether one’s emotional state
or own behaviour causes BC, and (iv) mammography
frequency recommendations). In all of our findings,
limited knowledge was found to be significantly associ-
ated with attendance to the first screening invitation, re-
attendance, lifetime mammography use and compliance
with recommended time intervals. This calls for urgent
renewed health education and tailored information on
the importance of screening while addressing misunder-
standings, debunking screening myths and improving
knowledge gaps. All of our findings in this study, and
when considered in the light of our previous results, can
be used to lead the development of current non-existent,
evidence-based interventions in Malta.
Strengths and limitations
Our group of ‘real’ non-attendees came from the same
target screening group, which further strengthens the
value of our data. Additionally, the rich dataset allowed
for diverse subgroup analyses, which facilitated an over-
view of lifetime screening practices, though not without
possible response bias as a possible weakness. An
additional strength is that the 121-item tool (MBSQ)
contains information that makes it possible to adjust
the analyses for potential confounders. Some aspects of
study limitations should be considered. One limitation
of the study is its cross-sectional design, which does
not allow for the associations of non-attendance with
socio-demographic factors such as age to be studied
over time. Future research is needed to evaluate a
potential cause effect relation. A problem in some of
the analyses is the low number of ‘real’ non-attendees,
hence a lower level of confidence in the results for this
particular group. This may have led to a type I and/or
type II error in relation to some of the analysed factors.
Another limitation of this study is that self-reports for
private mammography was used to measure lifetime
mammography rather than objective data from private
mammographic screening clinics. However, no national
data records from private practices are currently available
to date in Malta. Hence, self-reports for lifetime mam-
mography use was the only possible method of data
collection. The findings are likely to be generalizable
and broadly applicable to other populations. Although
limited to the Maltese population, the representation
of our heterogeneous population derives from differ-
ent parts of the country. However, given the potential
for cultural differences, varied health care delivery
systems, and socioeconomic factors between coun-
tries, the generalizability of study results may be
somewhat limited.
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Conclusions
Our findings may be used to develop cognitive interven-
tions aimed at enhancing perceived benefits, reducing
perceived barriers, and modifying negative emotional rep-
resentations to BC in order to motivate women to start
undertaking mammography screening. In general, our
results are in line with differences reported in the litera-
ture between screening attendees and non-attendees, such
that non-attendees were less knowledgeable of the recom-
mended mammography frequency, had attitudinal,
emotional and motivational barriers, less socio-economic
support and were less confident in themselves and the
medical establishment. Additionally, our study showed
that health beliefs were the most significant predictors to
lifetime mammography screening behaviour. Hence,
screening organizers and public health officials should
target women’s perceived barriers and enhance cues to
action when reaching out to non-attendees. Further quali-
tative research is required to clarify the determinants and
consequences of emotional barriers, particularly fear
among the ‘real’ non-attending cohort, and also to evalu-
ate the need for a more targeted approach among this
hardest-to-reach group in order to understand the com-
plexity of their behavioural barriers.
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